Efficacy of brimonidine for transient IOP rise after cataract surgery

Efficacy of brimonidine for transient IOP rise after cataract surgery - Efficacy of brimonidine for transient IOP rise after cataract surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011691

Enrollment

Registered

2013-09-15

Start date

2013-09-15

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

Brimonidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1.Patients with glaucoma 2.Patients with a history of intraocular surgery past 6 momth. 3. Patients who have difficulty for IOP measurement with applanation tonometer. 4.Patients who with a history of uveitis, ocular infection, and severe dry eye. 5.Patients who are treated with steroids or any NSAIDs. 6. Patients who have cardiovascular disease, cerebrovascular disease, and hypotension. 7.patients with diabetes mellitus. 8. Patients who the investigator consider ineligible for enrolment.

Design outcomes

Primary

Measure	Time frame
IOP	—

Countries

Japan

Contacts

Public ContactKaori Ideguchi

Hiroshima University Ophthalmology

ideguchi@hiroshima-u.ac.jp082-257-5247

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026